Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway

International Journal of Experimental Pathology

Volumn 83, Issue 1, 2002, Pages 1-20

  Lammas, D A ^a   De Heer, E ^b   Edgar, J D ^c   Novelli, V ^d   Ben Smith, A ^a   Baretto, R ^a   Drysdale, P ^a   Binch, J ^a   Maclennan, C ^a   Kumararatne, D S ^e   Panchalingam, S ^a   Ottenhoff, T H M ^b   Casanova, J L ^f   Emile, J F ^g  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 12;

DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; GRANULOMA; GRANULOMATOSIS; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; INTERFERON PRODUCTION; MYCOBACTERIOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRULENCE;

GENETIC PREDISPOSITION TO DISEASE; GRANULOMA; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; MUTATION; MYCOBACTERIUM INFECTIONS;

EID: 0036278876     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.2002.00216.x     Document Type: Review

References (77)

1. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
2. Interleukin-12 receptor beta1 deficiency in a patient with abdominal
3. Mendelian susceptibility to mycobacterial infection in man
4. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection
5. Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferon-gamma receptor
6. Interpreting cell wall 'Virulence factors' of Mycobacterium tuberculosis. Trends in
7. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease
8. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans
9. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene
10. Stimulation with cytokines enhances penetration of azithromycin into human macrophages
11. Infections caused by BCG and atypical mycobacteria in children: A new group of immune deficiencies
12. Idiopathicdisseminated bacillus Calmette-Guerin infection: A French national retrospective study
13. Immunological conditions of children with BCG disseminated infection
14. Interleukin 12 (IL-12) is crucial to development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
15. The role of S100+ macrophages and factor 13a dendritic cells in multibacillary leprosy
16. Inhibition of cellular responsiveness to interferon-γ (IFNγ) induced by over expression of inactive forms of IFNγ receptor
17. Inheritable defects in interleukin-12 and interferongamma mediated immunity and the TH1/TH2 paradigm in man
18. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice
19. A multicenter retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993
20. Mutation in the signaltransducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection
21. Interferon-gamma and interleukin-12 pathway defects and human disease
22. Viral infections in interferon-gamma receptor deficiency
23. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation
24. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion
25. Interferon-gamma receptor deficiency mimicking Langerhans' cell histiocytosis
26. Langerhans' cell histiocytosis cells are activated Langerhans' cells
27. Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection
28. Langerhans' cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffinembedded samples
29. High levels of interferon-γ in the serum of patients with complete interferon-γ receptor deficiency
30. Defective monocyte costimulation for IFNγ production in familial disseminated Mycobacterium avium complex infection: Abnormal IL-12 regulation
31. Interleukin 12 deficiency associated with recurrent infections
32. Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factoralpha in human interferon-gamma receptor 1 deficiency
33. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: A preliminary report
34. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
35. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection
36. Infections in IFNGR-1-deficient children
37. A novel form of complete IFN-γ receptor 1 deficiency, cell-surface receptors fail to bind IFN-γ
38. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis
39. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection
40. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients
41. Vaccination against tuberculosis and leprosy
42. A role for IL- receptor expression and signal transduction in host defense in leprosy
43. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis
44. Clinical consequences of defects in the IL-12 dependent interferon gamma pathway
45. Diagnosis of defects in the type-1 cytokine pathway
46. Understanding the genetic basis of susceptibility to mycobacterial infection
47. Familial disseminated atypical mycobacterial infection in childhood: A human mycobacterial susceptibility gene?
48. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine response
49. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates
50. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-Alpha /Beta
51. The S100 family of multipurpose calciumbinding proteins
52. In situ immunophenotype of macrophages and lymphocytes in granuloma formation of tuberculous lymphadenitis in HIV-infected and immunocompetent patients
53. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection
54. Human deficiencies in type 1 cytokine receptors reveal the essential role of type 1 cytokines in immunity to intracellular bacteria
55. Novel immunodeficiencies reveal the essential role of type 1 cytokines in immunity to intracellular bacteria
56. Phagocytosis and killing of intracellular pathogens: Interaction between cytokines and antibiotics
57. Diagnosis and management of inheritable disorders of interferon-γ-mediated immunity
58. Inherited interleukin-12 deficiency: ILI2B. Genotype and clinical phenotype of 13 patients from 6 kindreds
59. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency
60. In vitro production of IFNγ correlates with CA repeat polymorphism in the human IFNγ gene
61. Rare polymorphisms in the promoter region of the human interleukin 12 p35 and interleukin-12 p40 sub-unit genes
62. A functional interleukin 12 receptor complex is composed of two b type cytokine receptor subunits
63. Histiocyte Disorders
64. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNγammaR1) deficiency: Mutational analysis and evaluation of therapeutic options
65. Depressed CD40 ligand expression contributes to reduced gamma interferon production in human tuberculosis
66. Restraining mycobacteria: Role of granulomas in mycobacterial infections
67. Disseminated infection with Mycobacterium avium: Part 1 - Clinical features, treatment and pathology
68. Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India
69. Human leukocyte antigen (HLA)-linked control of susceptibility to tuberculosis and association with HLA-DR types
70. Interleukin-12: A cytokine at the interface of inflammation and immunity
71. Production of IL-18 in human tuberculosis
72. Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor b1 (IL-12Rβ1): Evidence for an IL-12Rβ1-independent pathway of IL-12 responsiveness in human T cells
73. Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation
74. Characterization of IL-12 receptor beta1 chain (IL-12Rbeta1)- deficient mice: IL-12Rbeta1 is an essential component of the functional mouse IL-12 receptor
75. Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis